EP3112372
Pantóþenatafleiður til meðhöndlunar á taugaröskunum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
26.4.2013EP published:
7.11.2018EP application number:
16001739.8
EP translation filed:
5.12.2018Grant published:
15.1.2019EPO information:
European Patent Register
Max expiry date:
25.4.2033Expiry date:
25.4.2020
Title:
PANTOTHENATE DERIVATIVES FOR THE TREATMENT OF NEUROLOGIC DISORDERS
Timeline
Today
26.4.2013EP application
7.11.2018EP Publication
5.12.2018Translation submitted
15.1.2019Registration published
25.4.2020Expires
Owner
Name:
Retrophin, Inc.Address:
3721 Valley Centre Drive, Suite 200, 92130, San Diego, CA, US
Inventor
Name:
Vaino, AndrewAddress:
San Diego, CA, US
Name:
Biestek, MarekAddress:
San Diego, CA, US
Name:
Shkreli, MartinAddress:
San Diego, CA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261639602 PDate:
27.4.2012Country:
US
Classification
Categories:
C07F 9/24, A61P 25/28, A61K 31/661
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 2.4.2019
Expires: 25.4.2020
Payer: Sigurjónsson & Thor ehf.